These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer. Schuette A; Lander DP; Kallogjeri D; Collopy C; Goddu S; Wildes TM; Daly M; Piccirillo JF JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):106-112. PubMed ID: 31750863 [TBL] [Abstract][Full Text] [Related]
3. Speech recognition and frequency of hearing loss in patients treated for cancer in childhood. Liberman PH; Schultz C; Goffi-Gomez MV; Lopes LF Pediatr Blood Cancer; 2013 Oct; 60(10):1709-13. PubMed ID: 23765953 [TBL] [Abstract][Full Text] [Related]
4. Cancer treatment in determination of hearing loss. Oliveira PF; Oliveira CS; Andrade JS; Santos TF; Oliveira-Barreto AC Braz J Otorhinolaryngol; 2016; 82(1):65-9. PubMed ID: 26549572 [TBL] [Abstract][Full Text] [Related]
5. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Das N; Kaushal D; Patro SK; Pareek P; Dixit A; Soni K; Prakasan Nair N; Choudhury B; Goyal A Acta Otolaryngol; 2021 Sep; 141(9):885-893. PubMed ID: 34486907 [TBL] [Abstract][Full Text] [Related]
6. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients. Scobioala S; Parfitt R; Matulat P; Kittel C; Ebrahimi F; Wolters H; Am Zehnhoff-Dinnesen A; Eich HT Strahlenther Onkol; 2017 Nov; 193(11):910-920. PubMed ID: 28887665 [TBL] [Abstract][Full Text] [Related]
7. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819 [TBL] [Abstract][Full Text] [Related]
8. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients. Waissbluth S; Del Valle Á; Chuang A; Becker A Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605 [TBL] [Abstract][Full Text] [Related]
9. Audiological findings in patients treated with radio- and concomitant chemotherapy for head and neck tumors. Dell'Aringa AH; Isaac ML; Arruda GV; Esteves MC; Dell'aringa AR; Júnior JL; Rodrigues AF Radiat Oncol; 2009 Nov; 4():53. PubMed ID: 19912669 [TBL] [Abstract][Full Text] [Related]
10. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected. Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725 [TBL] [Abstract][Full Text] [Related]
11. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients. Mahdavi SR; Rezaeyan A; Nikoofar A; Bakhshandeh M; Farahani S; Cheraghi S J Cancer Res Ther; 2020; 16(3):539-545. PubMed ID: 32719264 [TBL] [Abstract][Full Text] [Related]
12. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer. Zuur CL; Simis YJ; Lansdaal PE; Rasch CR; Tange RA; Balm AJ; Dreschler WA Audiol Neurootol; 2006; 11(5):318-30. PubMed ID: 16983183 [TBL] [Abstract][Full Text] [Related]
13. Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment. Deutsch BC; Collopy C; Kallogjeri D; Piccirillo JF JAMA Otolaryngol Head Neck Surg; 2021 Feb; 147(2):182-189. PubMed ID: 33300954 [TBL] [Abstract][Full Text] [Related]
14. Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa. Paken J; Govender CD; Pillay M; Feyasa M; Sewram V PLoS One; 2023; 18(4):e0283639. PubMed ID: 37014872 [TBL] [Abstract][Full Text] [Related]
15. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy. Abujamra AL; Escosteguy JR; Dall'Igna C; Manica D; Cigana LF; Coradini P; Brunetto A; Gregianin LJ Pediatr Blood Cancer; 2013 Mar; 60(3):474-8. PubMed ID: 22744939 [TBL] [Abstract][Full Text] [Related]
16. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860 [TBL] [Abstract][Full Text] [Related]
17. High prevalence of cisplatin-induced ototoxicity in Cape Town, South Africa. Whitehorn H; Sibanda M; Lacerda M; Spracklen T; Ramma L; Dalvie S; Ramesar R S Afr Med J; 2014 Apr; 104(4):288-91. PubMed ID: 25118554 [TBL] [Abstract][Full Text] [Related]
18. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis. Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the effect of chemotherapy and radiotherapy on the auditory function of children with cancer. Kingston JE; Abramovich S; Billings RJ; Malpas JS; Fuller AP Clin Otolaryngol Allied Sci; 1986 Dec; 11(6):403-9. PubMed ID: 3815865 [TBL] [Abstract][Full Text] [Related]
20. Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa. Paken J; Govender CD; Pillay M; Ayele BT; Sewram V BMC Cancer; 2021 Jul; 21(1):822. PubMed ID: 34271863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]